Lercanidipine (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Lercanidipine" in English language version.

refsWebsite
Global rank English rank
4th place
4th place
2nd place
2nd place
11th place
8th place
3rd place
3rd place
low place
low place
800th place
676th place
low place
low place
low place
low place

books.google.com

doi.org

  • Barrios V, Escobar C, Navarro A, Barrios L, Navarro-Cid J, Calderón A (November 2006). "Lercanidipine is an effective and well tolerated antihypertensive drug regardless the cardiovascular risk profile: The LAURA study". International Journal of Clinical Practice. 60 (11): 1364–1370. doi:10.1111/j.1742-1241.2006.01176.x. PMC 1636683. PMID 17073834.
  • Grassi G, Robles NR, Seravalle G, Fici F (2017). "Lercanidipine in the Management of Hypertension: An Update". Journal of Pharmacology & Pharmacotherapeutics. 8 (4): 155–165. doi:10.4103/jpp.JPP_34_17. PMC 5820745. PMID 29472747.
  • Makarounas-Kirchmann K, Glover-Koudounas S, Ferrari P (August 2009). "Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers". Clinical Therapeutics. 31 (8): 1652–1663. doi:10.1016/j.clinthera.2009.08.010. PMID 19808126. S2CID 42580226.
  • Klotz U (2002). "Interaction potential of lercanidipine, a new vasoselective dihydropyridine calcium antagonist". Arzneimittel-Forschung. 52 (3): 155–161. doi:10.1055/s-0031-1299873. PMID 11963641. S2CID 38892707.
  • Vincent J, Harris SI, Foulds G, Dogolo LC, Willavize S, Friedman HL (November 2000). "Lack of effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of amlodipine". British Journal of Clinical Pharmacology. 50 (5): 455–463. doi:10.1046/j.1365-2125.2000.00283.x. PMC 2014412. PMID 11069440.
  • Chen K, Zhang J, Liu S, Zhang D, Teng Y, Wei C, et al. (June 2012). "Simultaneous determination of lercanidipine, benazepril and benazeprilat in plasma by LC-MS/MS and its application to a toxicokinetics study". Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 899: 1–7. doi:10.1016/j.jchromb.2012.04.014. PMID 22622066.

espacenet.com

worldwide.espacenet.com

  • US 6852737, Bonifacio F, Campana F, De Iasi G, Leonardi A, "Crude and crystalline forms of lercanidipine hydrochloride", issued 8 February 2005, assigned to Recordati Ireland Ltd. 

kup.at

medsafe.govt.nz

ncats.io

drugs.ncats.io

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Barrios V, Escobar C, Navarro A, Barrios L, Navarro-Cid J, Calderón A (November 2006). "Lercanidipine is an effective and well tolerated antihypertensive drug regardless the cardiovascular risk profile: The LAURA study". International Journal of Clinical Practice. 60 (11): 1364–1370. doi:10.1111/j.1742-1241.2006.01176.x. PMC 1636683. PMID 17073834.
  • Grassi G, Robles NR, Seravalle G, Fici F (2017). "Lercanidipine in the Management of Hypertension: An Update". Journal of Pharmacology & Pharmacotherapeutics. 8 (4): 155–165. doi:10.4103/jpp.JPP_34_17. PMC 5820745. PMID 29472747.
  • Makarounas-Kirchmann K, Glover-Koudounas S, Ferrari P (August 2009). "Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers". Clinical Therapeutics. 31 (8): 1652–1663. doi:10.1016/j.clinthera.2009.08.010. PMID 19808126. S2CID 42580226.
  • Klotz U (2002). "Interaction potential of lercanidipine, a new vasoselective dihydropyridine calcium antagonist". Arzneimittel-Forschung. 52 (3): 155–161. doi:10.1055/s-0031-1299873. PMID 11963641. S2CID 38892707.
  • Vincent J, Harris SI, Foulds G, Dogolo LC, Willavize S, Friedman HL (November 2000). "Lack of effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of amlodipine". British Journal of Clinical Pharmacology. 50 (5): 455–463. doi:10.1046/j.1365-2125.2000.00283.x. PMC 2014412. PMID 11069440.
  • Chen K, Zhang J, Liu S, Zhang D, Teng Y, Wei C, et al. (June 2012). "Simultaneous determination of lercanidipine, benazepril and benazeprilat in plasma by LC-MS/MS and its application to a toxicokinetics study". Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 899: 1–7. doi:10.1016/j.jchromb.2012.04.014. PMID 22622066.

ncbi.nlm.nih.gov

  • Barrios V, Escobar C, Navarro A, Barrios L, Navarro-Cid J, Calderón A (November 2006). "Lercanidipine is an effective and well tolerated antihypertensive drug regardless the cardiovascular risk profile: The LAURA study". International Journal of Clinical Practice. 60 (11): 1364–1370. doi:10.1111/j.1742-1241.2006.01176.x. PMC 1636683. PMID 17073834.
  • Grassi G, Robles NR, Seravalle G, Fici F (2017). "Lercanidipine in the Management of Hypertension: An Update". Journal of Pharmacology & Pharmacotherapeutics. 8 (4): 155–165. doi:10.4103/jpp.JPP_34_17. PMC 5820745. PMID 29472747.
  • Vincent J, Harris SI, Foulds G, Dogolo LC, Willavize S, Friedman HL (November 2000). "Lack of effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of amlodipine". British Journal of Clinical Pharmacology. 50 (5): 455–463. doi:10.1046/j.1365-2125.2000.00283.x. PMC 2014412. PMID 11069440.

semanticscholar.org

api.semanticscholar.org